Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

Ann Rheum Dis. 2020 Feb;79(2):304-307. doi: 10.1136/annrheumdis-2019-216367. Epub 2019 Nov 11.
No abstract available

Keywords: B cells; antiphospholipid antibodies; systemic lupus erythematosus.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Antiphospholipid / blood
  • Antibodies, Antiphospholipid / drug effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / immunology
  • Male
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antibodies, Antiphospholipid
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • belimumab